Mucocutaneous toxicities are often observed during chemotherapy, in particular during therapy with targeted drugs, causing significant morbidity. The prevention and treatment of these toxicities are important not only to improve quality of life (QoL) but also to avoid unnecessary dose reduction or interruption, which can have a negative effect on treatment outcome. Proactive dermatologic treatment can reduce skin's toxicity grade and consequently clinical outcomes, compliance, and QoL in patients with advanced colorectal cancer.
Skin Toxicities During Colorectal Cancer Chemotherapy: Incidence and Pearls of Treatment in Our Experience / Panariello, L.; Donnarumma, M.; Iaffaioli, R. V.; Chiodini, P.; Annunziata, M. C.; Peduto, T.; Fabbrocini, G.. - In: CLINICAL COLORECTAL CANCER. - ISSN 1533-0028. - 19:4(2020), pp. e235-e242. [10.1016/j.clcc.2020.05.006]
Skin Toxicities During Colorectal Cancer Chemotherapy: Incidence and Pearls of Treatment in Our Experience
Chiodini P.;Annunziata M. C.;Peduto T.;Fabbrocini G.
2020
Abstract
Mucocutaneous toxicities are often observed during chemotherapy, in particular during therapy with targeted drugs, causing significant morbidity. The prevention and treatment of these toxicities are important not only to improve quality of life (QoL) but also to avoid unnecessary dose reduction or interruption, which can have a negative effect on treatment outcome. Proactive dermatologic treatment can reduce skin's toxicity grade and consequently clinical outcomes, compliance, and QoL in patients with advanced colorectal cancer.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
